Nudge study aims to boost colon cancer screening in 20,000 patients

NCT ID NCT05693649

Ongoing Knowledge-focused Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether sending patients direct reminders and giving their doctors electronic nudges can increase colorectal cancer screening rates. About 20,000 adults aged 50-72 who are overdue for screening will be randomly assigned to receive different types of outreach or usual care. The goal is to see which approach gets more people screened over three years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral interventions (direct patient outreach, clinician nudges, text reminders)
What this could lead to: If successful, this could show that simple outreach and reminders significantly increase colorectal cancer screening rates in primary care.
What could go wrong: This is a behavioral study, not a drug trial, so results depend on patient and clinician engagement. It may not work in other healthcare settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Locations

Penn Medicine

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.